Oct 26, 2016 12:32 pm UTC| Business
NOVATO, Calif, Oct. 26, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the initiation of...
MetaBank® and H&R Block® Announce Program to Offer Interest-Free Tax Refund Advances
Oct 26, 2016 12:32 pm UTC| Business
SIOUX FALLS, S.D., Oct. 26, 2016 -- Meta Financial Group, Inc.’s (NASDAQ:CASH) bank subsidiary, MetaBank®, has entered into an agreement with certain HR Block entities to originate up to $1.45 billion and retain up to...
Altimmune Announces Poster Presentation of HepTcell Program at 2017 Keystone Symposia Conference
Oct 26, 2016 12:32 pm UTC| Business
GAITHERSBURG, Md., Oct. 26, 2016 -- Altimmune, Inc., a clinical stage immunotherapeutic company, today announced that a poster detailing the design and preclinical evaluation of its HepTcell immunotherapeutic for the...
Altimmune Announces Poster Presentation of HepTcell Program at 2017 Keystone Symposia Conference
Oct 26, 2016 12:32 pm UTC| Business
GAITHERSBURG, Md., Oct. 26, 2016 -- Altimmune, Inc., a clinical stage immunotherapeutic company, today announced that a poster detailing the design and preclinical evaluation of its HepTcell immunotherapeutic for the...
Oct 26, 2016 12:31 pm UTC| Business
SALT LAKE CITY, Oct. 26, 2016 -- Park City Group’s ReposiTrak®, the leading provider of Compliance Management and Track Trace solutions for food, pharma and dietary supplement safety, announces today that Karen...
AMSC to Report Second Quarter Financial Results on November 2, 2016
Oct 26, 2016 12:31 pm UTC| Business
DEVENS, Mass., Oct. 26, 2016 -- AMSC (NASDAQ:AMSC), a global solutions provider serving wind and power grid industry leaders, announced today that it plans to release its second quarter fiscal 2016 financial results...
Oct 26, 2016 12:30 pm UTC| Business
WALTHAM, Mass., Oct. 26, 2016 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today...